Average cost of multi drug-resistant tuberculosis treatment in Central African Republic
Central African Republic: Average cost of multi drug-resistant tuberculosis treatment was 1,043 constant 2022 US$ in 2024. ▼ Falling
Latest (2024)
1,043 constant 2022 US$
Change on year
unchanged
World rank
46th
of 92 countries
All-time high
2,000 constant 2022 US$
in 2017
All-time low
1,043 constant 2022 US$
in 2022
Years of data
7
2017–2024
Average cost of multi drug-resistant tuberculosis treatment in Central African Republic, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2024, average cost of multi drug-resistant tuberculosis treatment in Central African Republic stood at 1,043 constant 2022 US$. That is the lowest value across all 7 years on record.
That represents a change of down 47.9% over ten years.
Central African Republic ranks 46th of 92 countries on this measure, in the middle of the range.
Average cost of multi drug-resistant tuberculosis treatment in Central African Republic, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 2,000 constant 2022 US$ | — |
| 2018 | 1,192 constant 2022 US$ | -40.4% |
| 2019 | 1,192 constant 2022 US$ | +0.0% |
| 2020 | 1,192 constant 2022 US$ | +0.0% |
| 2022 | 1,043 constant 2022 US$ | -12.5% |
| 2023 | 1,043 constant 2022 US$ | +0.0% |
| 2024 | 1,043 constant 2022 US$ | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,461 constant 2022 US$ | 1,192 constant 2022 US$ | 2,000 constant 2022 US$ | 3 |
| 2020s | 1,080 constant 2022 US$ | 1,043 constant 2022 US$ | 1,192 constant 2022 US$ | 4 |
Countries ranked near Central African Republic
More health data for Central African Republic
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,728 deaths (2100)
- Population ages 50-54, male, annual growth rate -1.96 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, per capita 0.0078 units per person (2025)
- Population ages 55-59, female, annual growth rate 0.7258 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0109 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Central African Republic?
- Average cost of multi drug-resistant tuberculosis treatment in Central African Republic was 1,043 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Central African Republic?
- The highest recorded value was 2,000 constant 2022 US$ in 2017.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Central African Republic?
- The lowest recorded value was 1,043 constant 2022 US$ in 2022.
- How does Central African Republic rank for average cost of multi drug-resistant tuberculosis treatment?
- Central African Republic ranks 46th out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Central African Republic?
- Over the last ten years it is down 47.9%. The long-run trend across the full record is falling.
- Where does this Central African Republic data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.